Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 25,473 | 2,716 | 2,069 | 47,441 | 2,006 |
| Gross Profit | 25,473 | 2,716 | 2,069 | 47,441 | 2,006 |
| Operating Expenses | 27,407 | 15,606 | 16,296 | 21,517 | 13,840 |
| Operating Income | -1,934 | -12,890 | -14,227 | 25,924 | -11,834 |
| Other Income | 940 | 976 | 961 | 847 | 159 |
| Pre-tax Income | -994 | -11,914 | -13,266 | 26,771 | -11,675 |
| Income Tax | 2,211 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -3,205 | -11,914 | -13,266 | 26,771 | -11,675 |
| Net Income | $-3,205 | $-11,914 | $-13,266 | $26,771 | $-11,675 |
| EPS Basic Total Ops | -0.06 | -0.23 | -0.25 | 0.98 | -0.33 |
| EPS Basic Continuous Ops | -0.06 | -0.23 | -0.25 | 0.97 | -0.33 |
| EPS Diluted Total Ops | -0.06 | -0.23 | -0.25 | 0.98 | -0.33 |
| EPS Diluted Continuous Ops | -0.06 | -0.23 | -0.25 | 0.97 | -0.33 |
| EBITDA(a) | $-1,826 | $-12,782 | $-14,114 | $26,053 | $-11,577 |